U.S. International Trade Commission Requests Public Comments on Balloon Dilation Devices Violation
Estimated reading time: 2–4 minutes
The U.S. International Trade Commission has shared important news. On June 26, 2026, a judge made a decision. This judge is called an administrative law judge. The decision is about a section called 337. The decision talks about a violation. It includes a recommendation on what to do next.
The Commission is asking people to send their thoughts. These thoughts should be about public interest. This is if the Commission finds a violation. They want comments from the public and government agencies only.
If you want to know more, you can contact Paul Lall. He works for the U.S. International Trade Commission. You can call him at (202) 205-2043.
To understand the document better, you can see it online. Go to https://edis.usitc.gov. If you need help, you can send an email to the address in the document.
The issue is about balloon dilation devices and systems. These are important medical tools. They are from companies named Fiagon GmbH, Fiagon NA, LLC, and Hemostasis, LLC.
People are asked to send short comments. These comments should be no more than five pages. They should focus on public health, safety, and the U.S. economy.
The Commission wants to know if other companies in the U.S. can make these products. They also want to know the impact on consumers if these products are excluded.
Comments must be sent by July 30, 2026. When sending, mention the investigation number: Inv. No. 337-TA-1449.
If you want your comments to stay private, mark them as confidential. You still need to send a non-confidential version too.
The Commission will review all comments. This is important to ensure the right decision for the public and economy.
This update follows the Tariff Act of 1930 and Commission rules. Lisa Barton, the Secretary to the Commission, released this information on June 29, 2026.
Legal Disclaimer
This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
